TY  - GEN
AU  - Isakoff,Steven J
AU  - Puhalla,Shannon
AU  - Domchek,Susan M
AU  - Friedlander,Michael
AU  - Kaufman,Bella
AU  - Robson,Mark
AU  - Telli,Melinda L
AU  - Diéras,Véronique
AU  - Han,Hyo Sook
AU  - Garber,Judy E
AU  - Johnson,Eric F
AU  - Maag,David
AU  - Qin,Qin
AU  - Giranda,Vincent L
AU  - Shepherd,Stacie P
TI  - A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale
SN  - 1744-8301
PY  - 2017///0223
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - BRCA1 Protein
KW  - genetics
KW  - BRCA2 Protein
KW  - Benzimidazoles
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Carboplatin
KW  - Clinical Protocols
KW  - Dacarbazine
KW  - Drug Monitoring
KW  - Female
KW  - Humans
KW  - Models, Statistical
KW  - Paclitaxel
KW  - Research Design
KW  - Sample Size
KW  - Temozolomide
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.2217/fon-2016-0412
ER  -